Securities code: Fujian Cosunter Pharmaceutical Co.Ltd(300436) securities abbreviation: Fujian Cosunter Pharmaceutical Co.Ltd(300436) Announcement No.: 2022037 Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Suggestive announcement on the disclosure of 2021 Annual Report
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”) held the 13th meeting of the 4th board of directors and the 12th meeting of the 4th board of supervisors on April 21, 2022, deliberated and adopted the proposal on the annual report 2021 and its summary.
In order to enable the majority of investors to fully understand the company’s operating results and financial status in 2021, the company’s 2021 annual report and the summary of 2021 annual report will be published on the gem information disclosure website cninfo (www.cn. Info. Com. CN.) designated by the China Securities Regulatory Commission on April 22, 2022 Investors are kindly requested to pay attention to it.
It is hereby announced.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors April 21, 2022
